Lopez Joseph J, Cooper Jennifer N, Fischer Beth A, Gonzalez Dani O, Deans Katherine J, Minneci Peter C
1 Center for Surgical Outcomes Research, Nationwide Children's Hospital , Columbus, Ohio.
2 Department of Pediatric Surgery, Nationwide Children's Hospital , Columbus, Ohio.
Surg Infect (Larchmt). 2017 Nov/Dec;18(8):890-893. doi: 10.1089/sur.2017.153. Epub 2017 Oct 10.
Pilonidal disease is a common and painful disorder that can be challenging to manage. Recurrent surgical treatment is often warranted and may result in significant morbidity, with reported wound complication rates as high as 30%. Laser hair depilation of the natal cleft may decrease the incidence of recurrence. The purpose of this study was to assess the safety and tolerability of laser hair depilation in adolescents with pilonidal disease.
We performed a prospective, single arm, pilot trial of laser hair depilation to the natal cleft in 13 patients with pilonidal disease. Each patient received an outpatient laser depilation treatment every four weeks with a goal of five total treatments. Follow-up tolerability was measured after each treatment by obtaining Likert scale, patient-reported, pain scores immediately after laser treatment and every six hours post-treatment, for the first 24 hours. Consistent pain scores <4 were used as a proxy for tolerability. The primary end point was tolerability and safety, defined as pain scores consistently <4 and no deep second-degree burns during the 24-hour post-treatment period. The secondary end point was disease recurrence at one year.
Thirteen patients were enrolled with 12 patients completing five laser depilation treatment sessions and one patient completing only four. There was 100% tolerability of treatments with no occurrence of second-degree burns. No patient was unable to complete a treatment session because of discomfort. Significantly diminished hair growth was noted after three treatments. All 13 patients were recurrence-free at a median follow-up of 13 months post-treatment initiation.
Laser hair depilation is safe and well tolerated in adolescents with pilonidal disease and may be effective at decreasing pilonidal disease recurrence. A prospective randomized controlled trial is planned to determine effectiveness of laser hair depilation compared with chemical/mechanical depilation methods in preventing pilonidal disease recurrence.
藏毛疾病是一种常见且疼痛的病症,治疗起来颇具挑战性。反复进行手术治疗往往是必要的,但可能会导致严重的并发症,据报道伤口并发症发生率高达30%。对臀裂进行激光脱毛可能会降低复发率。本研究的目的是评估激光脱毛在患有藏毛疾病的青少年中的安全性和耐受性。
我们对13例藏毛疾病患者进行了一项前瞻性、单臂、激光脱毛至臀裂的试点试验。每位患者每四周接受一次门诊激光脱毛治疗,目标是总共进行五次治疗。在每次治疗后,通过获取李克特量表、患者报告的激光治疗后立即及治疗后每六小时的疼痛评分,持续24小时,来测量随访耐受性。持续疼痛评分<4被用作耐受性的指标。主要终点是耐受性和安全性,定义为治疗后24小时内疼痛评分持续<4且无深度二度烧伤。次要终点是一年时疾病复发情况。
13例患者入组,12例患者完成了五次激光脱毛治疗疗程,1例患者仅完成了四次。治疗的耐受性为100%,未发生二度烧伤。没有患者因不适而无法完成一个治疗疗程。三次治疗后毛发显著减少。在治疗开始后的中位随访13个月时,所有13例患者均无复发。
激光脱毛在患有藏毛疾病的青少年中是安全且耐受性良好的,可能对降低藏毛疾病复发有效。计划进行一项前瞻性随机对照试验,以确定与化学/机械脱毛方法相比,激光脱毛在预防藏毛疾病复发方面的有效性。